What is the share price of Astec Lifesciences Ltd (ASTEC) today?
The share price of ASTEC as on 5th December 2025 is ₹774.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Astec Lifesciences Ltd (ASTEC) share?
The past returns of Astec Lifesciences Ltd (ASTEC) share are- Past 1 week: -5.65%
- Past 1 month: 27.21%
- Past 3 months: -4.48%
- Past 6 months: 12.86%
- Past 1 year: -24.36%
- Past 3 years: -58.75%
- Past 5 years: -15.89%
What are the peers or stocks similar to Astec Lifesciences Ltd (ASTEC)?
The peers or stocks similar to Astec Lifesciences Ltd (ASTEC) include:What is the market cap of Astec Lifesciences Ltd (ASTEC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Astec Lifesciences Ltd (ASTEC) is ₹2044.04 Cr as of 5th December 2025.What is the 52 week high and low of Astec Lifesciences Ltd (ASTEC) share?
The 52-week high of Astec Lifesciences Ltd (ASTEC) is ₹1254.26 and the 52-week low is ₹607.05.What is the PE and PB ratio of Astec Lifesciences Ltd (ASTEC) stock?
The P/E (price-to-earnings) ratio of Astec Lifesciences Ltd (ASTEC) is -15.17. The P/B (price-to-book) ratio is 8.70.Which sector does Astec Lifesciences Ltd (ASTEC) belong to?
Astec Lifesciences Ltd (ASTEC) belongs to the Materials sector & Fertilizers & Agro Chemicals sub-sector.How to buy Astec Lifesciences Ltd (ASTEC) shares?
You can directly buy Astec Lifesciences Ltd (ASTEC) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Astec Lifesciences Ltd
ASTEC Share Price
774.504.96% (-40.40)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ASTEC Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ASTEC Performance & Key Metrics
ASTEC Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -17.94 | 8.70 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.82 | 3.18 | 1.63% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
ASTEC Company Profile
Astec LifeSciences Limited is a holding company. The Company is a producer of agrochemicals and pharmaceutical intermediates.
COROMANDEL
PE Ratio
32.84
32.84
1Y Return
31.03%
31.03%
Buy Reco %
90.00
90.00
UPL
PE Ratio
71.18
71.18
1Y Return
33.19%
33.19%
Buy Reco %
83.33
83.33
PE Ratio
1,315.96
1,315.96
1Y Return
16.36%
16.36%
Buy Reco %
0.00
0.00
BAYERCROP
PE Ratio
35.65
35.65
1Y Return
26.08%
26.08%
Buy Reco %
50.00
50.00
CHAMBLFERT
PE Ratio
10.53
10.53
1Y Return
18.89%
18.89%
Buy Reco %
50.00
50.00
ASTEC Forecast
ASTEC Forecasts
Price
Revenue
Earnings
ASTEC Share Price Forecast
ASTEC Share Price Forecast
2025
Current
₹814.90
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹814.90
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ASTEC Company Revenue Forecast
ASTEC Company Revenue Forecast
2025
Current
₹386.93
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹386.93
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
ASTEC Stock EPS (Earnings Per Share) Forecast
ASTEC Stock EPS (Earnings Per Share) Forecast
2025
Current
₹-68.22
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹-68.22
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ASTEC
ASTEC
Income
Balance Sheet
Cash Flow
Annual Normal View
ASTEC Income Statement
ASTEC Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 301.53 | 395.02 | 442.06 | 534.54 | 562.79 | 687.04 | 641.23 | 463.82 | 386.93 | 382.52 | ||||||||||
Raw Materials | 179.66 | 224.22 | 295.05 | 333.81 | 344.60 | 444.82 | 460.83 | 318.82 | 248.86 | 396.08 | ||||||||||
| Power & Fuel Cost | 15.75 | 17.87 | 23.80 | 28.80 | 25.28 | 38.04 | 45.68 | 35.87 | 34.08 | |||||||||||
| Employee Cost | 20.38 | 21.71 | 25.10 | 29.92 | 38.35 | 50.31 | 52.26 | 61.74 | 61.10 | |||||||||||
| Selling & Administrative Expenses | 13.65 | 16.74 | 15.41 | 21.83 | 17.17 | 23.55 | 25.77 | 20.97 | 22.44 | |||||||||||
| Operating & Other expenses | 17.44 | 33.43 | -4.93 | 23.07 | 17.92 | -34.22 | -32.63 | 26.69 | 81.03 | |||||||||||
EBITDA | 54.65 | 81.05 | 87.63 | 97.11 | 119.47 | 164.54 | 89.32 | -0.27 | -60.58 | -13.56 | ||||||||||
| Depreciation/Amortization | 13.68 | 14.68 | 19.35 | 23.16 | 25.66 | 34.36 | 33.65 | 36.25 | 43.71 | 44.91 | ||||||||||
| PBIT | 40.97 | 66.37 | 68.28 | 73.95 | 93.81 | 130.18 | 55.67 | -36.52 | -104.29 | -58.47 | ||||||||||
| Interest & Other Items | 12.24 | 10.66 | 12.38 | 12.59 | 4.75 | 9.06 | 20.71 | 25.23 | 36.70 | 39.76 | ||||||||||
| PBT | 28.73 | 55.71 | 55.90 | 61.36 | 89.06 | 121.12 | 34.96 | -61.75 | -140.99 | -98.23 | ||||||||||
| Taxes & Other Items | 9.62 | 20.81 | 20.17 | 13.84 | 24.02 | 31.26 | 9.39 | -14.81 | -6.24 | 15.69 | ||||||||||
| Net Income | 19.11 | 34.90 | 35.73 | 47.52 | 65.04 | 89.86 | 25.57 | -46.94 | -134.75 | -113.92 | ||||||||||
| EPS | 9.74 | 17.75 | 18.15 | 24.12 | 32.98 | 45.53 | 12.95 | -23.77 | -68.22 | -57.67 | ||||||||||
| DPS | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.15 | 0.08 | 0.08 | 0.06 | 0.05 | 0.03 | 0.11 | 0.00 | 0.00 | 0.00 |
ASTEC Company Updates
ASTEC Stock Peers
ASTEC Past Performance & Peer Comparison
ASTEC Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsFertilizers & Agro Chemicals
Compare valuation on Screener
MaterialsFertilizers & Agro Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Astec Lifesciences Ltd | -15.17 | 8.70 | — |
| Coromandel International Ltd | 32.84 | 6.05 | 0.65% |
| UPL Ltd | 71.18 | 1.69 | 0.79% |
| Fertilisers And Chemicals Travancore Ltd | 1,315.96 | 39.57 | 0.05% |
ASTEC Stock Price Comparison
Compare ASTEC with any stock or ETFCompare ASTEC with any stock or ETF
ASTEC
ASTEC Holdings
ASTEC Shareholdings
ASTEC Promoter Holdings Trend
ASTEC Promoter Holdings Trend
Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 1.54%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ASTEC Institutional Holdings Trend
ASTEC Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ASTEC Shareholding Pattern
ASTEC Shareholding Pattern
ASTEC Shareholding History
ASTEC Shareholding History
Foreign Institutions
Mutual Funds Invested in ASTEC
Mutual Funds Invested in ASTEC
No mutual funds holding trends are available
Top 5 Mutual Funds holding Astec Lifesciences Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.6270% | Percentage of the fund’s portfolio invested in the stock 0.05% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 167/252 (+58) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.3965% | Percentage of the fund’s portfolio invested in the stock 0.27% | Change in the portfolio weight of the stock over the last 3 months -0.13% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 41/61 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0559% | Percentage of the fund’s portfolio invested in the stock 0.02% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 90/95 (-2) |
Compare 3-month MF holding change on Screener
smallcases containing ASTEC stock
smallcases containing ASTEC stock
Looks like this stock is not in any smallcase yet.
ASTEC Events
ASTEC Events
ASTEC Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ASTEC Dividend Trend
No dividend trend available
ASTEC Upcoming Dividends
ASTEC Upcoming Dividends
No upcoming dividends are available
ASTEC Past Dividends
ASTEC Past Dividends
Cash Dividend
Ex DateEx DateJul 21, 2023
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateJul 19, 2022
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 19, 2022
Cash Dividend
Ex DateEx DateJul 22, 2021
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 22, 2021
Cash Dividend
Ex DateEx DateJul 16, 2020
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 16, 2020
Cash Dividend
Ex DateEx DateJul 18, 2019
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 18, 2019
ASTEC Stock News & Opinions
ASTEC Stock News & Opinions
Articles & Videos
Earnings
Astec Lifesciences reports consolidated net loss of Rs 24.43 crore in the September 2025 quarter
Net Loss of Astec Lifesciences reported to Rs 24.43 crore in the quarter ended September 2025 as against net loss of Rs 38.56 crore during the previous quarter ended September 2024. Sales declined 25.20% to Rs 73.72 crore in the quarter ended September 2025 as against Rs 98.55 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales73.7298.55 -25 OPM %-9.07-20.03 - PBDT-13.97-27.07 48 PBT-24.41-38.54 37 NP-24.43-38.56 37 Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Astec Lifesciences reports standalone net loss of Rs 24.45 crore in the September 2025 quarter
Net Loss of Astec Lifesciences reported to Rs 24.45 crore in the quarter ended September 2025 as against net loss of Rs 38.57 crore during the previous quarter ended September 2024. Sales declined 25.20% to Rs 73.72 crore in the quarter ended September 2025 as against Rs 98.55 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales73.7298.55 -25 OPM %-9.05-20.01 - PBDT-13.99-27.08 48 PBT-24.45-38.57 37 NP-24.45-38.57 37 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Astec Lifesciences declare Quarterly Result
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 29 October 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Astec Lifesciences reports consolidated net loss of Rs 33.04 crore in the June 2025 quarter
Net Loss of Astec Lifesciences reported to Rs 33.04 crore in the quarter ended June 2025 as against net loss of Rs 39.72 crore during the previous quarter ended June 2024. Sales rose 31.30% to Rs 91.08 crore in the quarter ended June 2025 as against Rs 69.37 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales91.0869.37 31 OPM %-12.07-66.67 - PBDT-21.52-52.37 59 PBT-33.02-61.64 46 NP-33.04-39.72 17 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Astec Lifesciences schedules board meeting
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 28 July 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Astec Lifesciences to convene board meeting
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 30 June 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Spotlight
Astec Life gains after board approves rights issue of up to Rs 250-cr
In a regulatory filing, the company said its board, at a meeting held on Tuesday, 24 June 2025, approved the issuance of fully paid-up equity shares with a face value of Rs 10 each for an amount not exceeding Rs 250 crore. The rights issue will be offered to eligible equity shareholders as of the record date, which will be announced in due course. Astec Lifesciences is into the manufacturing of agrochemical active ingredients (technical), bulk and formulations, and intermediate products, and it sells its products in India as well as exports them to approximately 24 countries. The company's consolidated net loss widened to Rs 16.08 crore in Q4 FY25 as against a net loss of Rs 0.964 crore reported in Q4 FY24. Revenue from operations declined 22.26% YoY to Rs 119.53 crore in the quarter ended 31 March 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Board of Astec LifeSciences approves rights issue of Rs 250 cr
The Board of Astec LifeSciences at its meeting held on 24 June 2025 has approved the issue of fully paid-up equity shares of the company of face value of Rs. 10/- each for an amount not exceeding Rs. 250 crore by way of a rights issue to the eligible equity shareholders of the company. Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Astec Lifesciences to hold board meeting
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 24 June 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Astec Lifesciences AGM scheduled
Astec Lifesciences announced that the 31th Annual General Meeting(AGM) of the company will be held on 28 July 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -6.26%, vs industry avg of 9.42%
Over the last 5 years, market share decreased from 0.38% to 0.17%